Emerald Health Therapeutics Inc. Asset Turnover Ratio (EMHTF), as of fourth quarter 2019, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Emerald Health Therapeutics Inc.  (EMHTF)
 

Emerald Health Therapeutics Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Emerald Health Therapeutics Inc. asset turnover ratio, the ability of Emerald Health Therapeutics Inc.'s assets to generate revenue in the fourth quarter 2019, increased sequentially to 0.25 in the fourth quarter (Dec 31 2019), a new company high.

Within sector 141 more businesses have achieved higher asset turnover ratio. While asset turnover ranking remained unchanged in the fourth quarter 2019 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EMHTF Asset Turnover Ratio (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Asset Change -24.38 % -24.38 % -24.38 % -24.38 % -
Y / Y Revenue Change 958.45 % 2895.44 % 1620.38 % 565.29 % -
Asset Turnover Ratio (TTM) 0.25 0.11 0.05 0.03 0.01
EMHTF's Total Ranking # # # # 4756 #
Seq. Asset Change 0 % 0 % 0 % -24.38 % 0 %
Seq. Revenue Change 132.49 % 94.19 % 93.11 % 21.41 % 557.94 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 142
Healthcare Sector # 406
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0.25 0.13 0.01
(Dec 31 2019)   (Dec 31 2018)




EMHTF Company Profile • Back to EMHTF Efficiency Comparisons • Compare EMHTF Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2019 Assets at quarter ending Dec 31 2019
Pfenex Inc   0.69 $ 50.326  Millions$ 72.620  Millions
Fonar Corporation  0.69 $ 91.580  Millions$ 132.364  Millions
Neos Therapeutics Inc   0.69 $ 64.649  Millions$ 93.495  Millions
Trinity Biotech Plc  0.69 $ 90.435  Millions$ 131.071  Millions
Lemaitre Vascular Inc   0.69 $ 117.232  Millions$ 170.317  Millions
Histogen Inc   0.69 $ 21.717  Millions$ 31.584  Millions
Dexcom Inc   0.68 $ 1,476.000  Millions$ 2,155.150  Millions
Amarin Corp Plcuk  0.68 $ 429.755  Millions$ 627.827  Millions
Cantel Medical Corp   0.68 $ 1,013.772  Millions$ 1,482.526  Millions
Axogen inc   0.68 $ 106.712  Millions$ 156.483  Millions
Insulet Corporation  0.68 $ 738.200  Millions$ 1,085.406  Millions
Mannkind Corporation  0.68 $ 63.038  Millions$ 92.905  Millions
Chembio Diagnostics Inc   0.68 $ 33.926  Millions$ 50.076  Millions
Veru Inc   0.68 $ 36.010  Millions$ 53.254  Millions
Resmed Inc   0.67 $ 2,784.406  Millions$ 4,178.676  Millions
Strata Skin Sciences Inc  0.66 $ 31.586  Millions$ 47.642  Millions
Alkermes Plc   0.66 $ 1,170.947  Millions$ 1,767.921  Millions
Avid Bioservices Inc   0.66 $ 64.207  Millions$ 97.733  Millions
H cyte Inc  0.66 $ 8.347  Millions$ 12.715  Millions
Prophase Labs Inc   0.66 $ 9.876  Millions$ 15.061  Millions
Baxter International Inc   0.66 $ 11,362.000  Millions$ 17,346.500  Millions
Labcorp Holdings Inc   0.65 $ 11,554.800  Millions$ 17,652.350  Millions
Heartbeam Inc   0.65 $ 439.107  Millions$ 671.509  Millions
Surmodics Inc   0.65 $ 100.452  Millions$ 154.061  Millions
Aveo Pharmaceuticals Inc   0.65 $ 28.795  Millions$ 44.632  Millions
Apollo Endosurgery inc   0.64 $ 50.713  Millions$ 78.940  Millions
Nuvasive Inc  0.64 $ 1,168.070  Millions$ 1,820.388  Millions
Arena Pharmaceuticals Inc   0.64 $ 806.431  Millions$ 1,257.690  Millions
Iradimed Corporation  0.64 $ 38.517  Millions$ 60.140  Millions
Adm Tronics Unlimited Inc   0.64 $ 3.260  Millions$ 5.097  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.